Larger clinical studies are needed to elucidate the relationship between circulating inflammatory markers and irisin in children with T2DM, as well as experimental studies to elucidate the mechanisms of hypoirisinemia in T2DM, as irisin may ultimately play a role as a therapeutic agent in obesity and in T2DM. The gene discussed is FNDC5; the disease is obesity disorder.